alexa Peyronies Disease | India | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Journals

Read more

Relevant Topics

Peyronies Disease

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Peyronies Disease

    Peyronie's disease (PD) is an inflammatory condition characterized by the formation of fibrous, noncompliant nodules in the tunica albuginea which can impede tunical expansion during penile erection, leading to deformity and bending. While the cause of this disease is thought to be due to microvascular trauma and abnormal wound healing, other hypotheses include genetic predisposition. In this review the pathophysiology of Peyronie's disease is discussed as well as current hypothese regarding its origin. Furthermore, there were significant associations between the risk factors for ED and PD, and with significant associations reported between PD and age, obesity, smoking, duration and number of cigarettes smoked per day. Dyslipidaemia, psychological disorders and the presence of at least one risk factor were significantly associated with PD. There were significant associations between a longer duration and poor metabolic control of diabetes and PD.
  • Peyronies Disease

    There is one medication approved by the Food and Drug Administration for the of Peyronie's disease. It's called collagenase Clostridium histolyticum (Xiaflex). The works by breaking down the buildup of collagen that causes penile curvature. It involves a series of in-office injections, directly into the penile lump, as well as penile modeling — brief exercises to gently stretch and straighten the penis. In clinical trials, this collagenase therapy significantly reduced curvature and bothersome symptoms associated with Peyronie's disease in many participants. Oral medication called pentoxifylline (Trental), verapamil (injections or topical gel) and interferon (injections).
  • Peyronies Disease

    Organizations along with the government encouraging many projects regarding the cure and further detailed studies of the disease.
  • Peyronies Disease

    The disease’s prevalence was found to be 9.7% and appeared to increase with age. In a follow-up study of 75 men, 30% reported a worsening of their signs and symptoms over time. 57%, the disease had stabilized after resolution of the inflammatory process, and, in 12%, symptoms had even disappeared spontaneously.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings

International Conferences 2017-18

Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Conferences By Continents

USA & Americas

Asia-Pacific & Middle East

Europe

Medical & Clinical Conferences

Conferences by Subject

Contact Us

Agri, Food, Aqua & Veterinary Science

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical & Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering & Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science & Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics & Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

Content of this site is vailable under  Creative Commons Attribution 4.0 License
Copyright © 2017 OMICS International All Rights Reserved.

adwords